Full Text
Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (Csu)

Abstract

Authors

J Graham D McBride D Stull A Halliday ST Alexopoulos M Balp M Griffiths I Agirrezabal A Brennan

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×